RAD51 and neoplasm: Functional assays for HR defects include (1) assessing tumor cell formation of post-damage RAD51 nuclear foci, and (2) challenging cells with DSB inducing agents such as gamma irradiation, PARP inhibitors, and platinum crosslinking agents [27].